Bristol-Myers Squibb Co

BMY

Company Profile

  • Business description

    Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

  • Contact

    Route 206 and Province Line Road
    Princeton
    New JerseyNJ08543
    USA

    T: +1 609 252-4621

    E: [email protected]

    https://www.bms.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    34,100

Bristol-Myers Squibb Co News & Analysis

stocks

10 cheap wide-moat US stocks for 2025

Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.
stocks

10 best US blue-chip stocks to buy for the long term

The stocks of these high-quality companies with large market capitalisations look undervalued today.
personal-finance

US stock market outlook: tariffs are 2025's wild card

Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,137.8014.900.16%
CAC 407,905.9275.810.97%
DAX 4023,632.08105.030.45%
Dow JONES (US)46,381.5466.270.14%
FTSE 1009,250.4123.730.26%
HKSE26,159.12185.02-0.70%
NASDAQ22,788.98157.500.70%
Nikkei 22545,493.66447.850.99%
NZX 50 Index13,136.545.00-0.04%
S&P 5006,693.750.000.00%
S&P/ASX 2008,845.9014.300.16%
SSE Composite Index3,821.836.74-0.18%

Market Movers